Anti Allergics Range

Anti Allergics Range — Saturn Formulations PCD Pharma Franchise

Allergic disorders — rhinitis, urticaria, conjunctivitis, atopic dermatitis, asthma, and food allergies — affect an estimated 20–30% of the Indian population, creating a massive, year-round demand for effective antiallergic medications. Saturn Formulations, a WHO-GMP and ISO-certified pharmaceutical manufacturer with over twelve years of formulation expertise, offers a comprehensive Anti-Allergics Range covering first-generation, second-generation, and third-generation antihistamines along with leukotriene receptor antagonists and decongestant-antihistamine combinations.

Our anti-allergic portfolio is designed to meet the prescription preferences of general physicians, ENT specialists, paediatricians, and pulmonologists — spanning from sedating antihistamines for acute urticaria to non-sedating agents for chronic allergic rhinitis management. Every product is manufactured under strict Good Manufacturing Practices and tested to pharmacopoeial standards before dispatch.

Why Choose Saturn Formulations Anti-Allergic Franchise?

• Year-Round Demand: Pollen seasons, dust mite exposure, food allergies, and air pollution make antiallergic prescriptions consistent throughout the year.
• Multi-Specialist Prescriber Base: ENT surgeons, general physicians, paediatricians, pulmonologists, and dermatologists all prescribe antihistamines regularly.
• Generational Coverage: First-gen (chlorpheniramine), second-gen (cetirizine, loratadine), and third-gen (levocetirizine, desloratadine, fexofenadine) agents cover all prescriber preferences.
• Combination Products: Montelukast-Levocetirizine, phenylephrine-antihistamine combinations provide high-margin premium SKUs.
• WHO-GMP Manufacturing: Regulatory compliance that gives prescribers and patients confidence in therapeutic outcome.
• Monopoly Territory Rights: Exclusive distribution ensures no internal competition from other Saturn franchise partners.

Our Anti-Allergic Product Portfolio

Second-Generation Antihistamines

Cetirizine Hydrochloride 5mg and 10mg tablets — the most commonly prescribed antihistamine in India. Loratadine 10mg for once-daily allergy control with excellent non-sedation profile. Both available in standard strip and blister packaging.

Third-Generation Antihistamines

Levocetirizine 2.5mg and 5mg, Desloratadine 5mg, and Fexofenadine 120mg and 180mg — preferred by ENT and allergy specialists for their superior selectivity and prolonged duration of action without CNS depression.

Leukotriene Receptor Antagonists and Combinations

Montelukast 10mg and 4mg chewable (paediatric). Montelukast 10mg + Levocetirizine 5mg combination tablets — one of the highest-prescribed allergy combinations in India for allergic rhinitis with bronchospasm. These combinations command premium MRP and deliver strong franchise margins.

Decongestant Combinations

Cetirizine + Phenylephrine, Loratadine + Pseudoephedrine, and Chlorpheniramine + Phenylephrine combinations for acute rhinitis with congestion. Ideal for general practice and pharmacy-direct dispensing during cold and flu seasons.

E-E-A-T: Our Expertise in Anti-Allergic Formulation

The bioavailability of antihistamines is critically affected by formulation decisions — particle size of API, polymorphic form selection, and film-coating thickness all influence the rate and extent of absorption. Saturn Formulations' formulation scientists apply dissolution modelling and bioequivalence principles to every antihistamine product to ensure clinical performance consistency batch after batch.

Our QC laboratory performs HPLC assay, optical rotation testing for chiral antihistamines, dissolution profiling, and stability studies per ICH Q1A(R2) guidelines. Retained samples from every batch are held for the full statutory period, ensuring complete post-market traceability.

Market Opportunity — Anti-Allergic Franchise

India's antihistamine and anti-allergic market is valued at over INR 3,000 crore and growing at a CAGR of approximately 9–11% driven by rising pollution levels, increasing allergen sensitisation, and greater diagnostic awareness. The launch of premium antihistamine combinations (Montelukast-Levocetirizine) has shifted the market toward higher-value SKUs — benefiting franchise partners who stock these products.

Seasonal demand peaks during harvest season, winter months, and high-pollen spring periods create predictable spikes in antihistamine orders — allowing franchise partners to plan inventory and capitalise on seasonal revenue surges.

Start Your Anti-Allergic PCD Franchise Today

1. Contact Saturn Formulations: +91-8729000609 | enquiry.saturn@gmail.com
2. Review our current anti-allergic catalogue and select your SKUs
3. Submit Drug License and GST registration certificates
4. Confirm your exclusive territory
5. Receive your first order and complete marketing kit within 72 hours

Saturn Formulations' anti-allergic franchise gives you access to one of India's most consistently demanded pharmaceutical segments, backed by certified quality, expert formulation science, and dedicated franchise support. Call today: +91-8729000609.